Koichi Hirao
Yokohama, 2210835, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Trends in the Management of Patients with Type 2 Diabetes Mellitus by Japanese Practitioners.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: August 27, 2025
Differences in Dental Care Referral for Diabetic Patients Between General Practitioners and Diabetes Specialists in Japan, Analyzed from NSAID-Study 3.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: November 09, 2021
Effect of canagliflozin on the overall clinical state including insulin resistance in Japanese patients with type 2 diabetes mellitus.
Journal: Diabetes research and clinical practice
Published: October 05, 2018
Current status of achieving blood pressure target and its clinical correlates in Japanese type 2 diabetes.
Journal: Journal of diabetes investigation
Published: July 22, 2017
Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38).
Journal: Journal of diabetes investigation
Published: May 27, 2015
Pharmacokinetic and pharmacodynamic properties of insulin degludec in Japanese patients with type 1 diabetes mellitus reflect similarities with Caucasian patients.
Journal: Journal of diabetes investigation
Published: January 12, 2015
Liraglutide Versus Sitagliptin in a 24-week, Multicenter, Open-label, Randomized, Parallel-group Study in Japanese Type 2 Diabetes Mellitus Patients Responding Inadequately to a Sulfonylurea and/or One or Two Other Oral Antidiabetic Drugs (JDDM 33).
Journal: Japanese clinical medicine
Published: April 20, 2014
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial.
Journal: Diabetes research and clinical practice
Published: March 27, 2014
Both glimepiride and high-dose metformin are important for sustained glucose lowering in Japanese type 2 diabetes patients on glimepiride-sitagliptin-metformin therapy: subanalysis of a single-center, open-label, randomized study.
Journal: Diabetes technology & therapeutics
Published: February 18, 2014
Evaluation of insulin regimens as an effective option for glycemic control in patients with type 2 diabetes: A propensity score-matched cohort study across Japan (JDDM31).
Journal: Journal of diabetes investigation
Published: August 28, 2013
Glimepiride strongly enhances the glucose-lowering effect in triple oral antidiabetes therapy with sitagliptin and metformin for Japanese patients with type 2 diabetes mellitus.
Journal: Diabetes technology & therapeutics
Published: March 14, 2013
Last Updated: 09/26/2026